George Soros's CRL Position Overview
George Soros (via Soros Fund Management LLC) currently holds 6,778 shares of Charles River Laboratories International, Inc. (CRL) worth $1.35 M, representing 0.02% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.
Based on recent 13F filings, George Soros has initiated a new position in CRL, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
George Soros's Charles River Laboratories International (CRL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Charles River Laboratories International (CRL) Trades by George Soros
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +6,778 | New Buy | 6,778 | $199.48 |
George Soros's Charles River Laboratories International Investment FAQs
George Soros first purchased Charles River Laboratories International, Inc. (CRL) in Q4 2025, acquiring 6,778 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
George Soros has held Charles River Laboratories International, Inc. (CRL) for 1 quarters since Q4 2025.
George Soros's largest addition to Charles River Laboratories International, Inc. (CRL) was in Q4 2025, adding 6,778 shares worth $1.35 M.
According to the latest 13F filing for Q4 2025, George Soros's firm, Soros Fund Management LLC, owns 6,778 shares of Charles River Laboratories International, Inc. (CRL), valued at approximately $1.35 M.
As of the Q4 2025 filing, Charles River Laboratories International, Inc. (CRL) represents approximately 0.02% of George Soros's publicly disclosed stock portfolio, making it one of their key holdings.
George Soros's peak holding in Charles River Laboratories International, Inc. (CRL) was 6,778 shares, as reported at the end of Q4 2025.